Market Cap 3.78M
Revenue (ttm) 0.00
Net Income (ttm) -10.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 167,700
Avg Vol 630,124
Day's Range N/A - N/A
Shares Out 4.27M
Stochastic %K 7%
Beta 1.09
Analysts Strong Buy
Price Target $2.00

Company Profile

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002 for the treatment of mild traumatic brain injury, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplif...

Industry: Biotechnology
Sector: Healthcare
Phone: 813 286 7900
Fax: 813 286 7900
Address:
1990 Main Street, Suite 750, Sarasota, United States
TritiumH3
TritiumH3 Mar. 17 at 8:20 PM
0 · Reply
NMax
NMax Mar. 17 at 6:25 PM
$OGEN Janet Huffman and the Oragenics board have created a culture of distrust regarding their company and their NYSE listing, by seemingly repeatedly and intentionally defrauding their own investors while colluding with shorters such as Sabby
0 · Reply
RocketQueen
RocketQueen Mar. 17 at 5:25 PM
$OGEN what a garbage stock and company. Every time I learn something new about J. Vandlandingham it reminds of how much this is a scam and fraud. Take what's left of your investment here and put it in a market index ETF or a dividend stock like Coca Cola.
0 · Reply
profitingstocks
profitingstocks Mar. 17 at 4:13 PM
$OGEN $8M cash on their current burn rate will last them until October at the very latest, more likely to be much sooner than that. Meaning they’ll be issuing some of those 100,000,000 shares they have authorised for their ATM offering any day now, if they’re not already. Absolutely nothing to look forward to here - even if, by some miracle, they manage to create a product they can sell and make money from for the first time ever, they’ll have destroyed 99.9999% of the stock price by then through capital raises and toxic financing
0 · Reply
SXCross
SXCross Mar. 17 at 3:40 PM
$OGEN Short-Interesse 570.220 Aktien – Quelle: NYSE
0 · Reply
SXCross
SXCross Mar. 17 at 3:38 PM
$OGEN Something's not right here: Market capitalization 3.27 million. Cash 8 million. No debt! Product candidate is valued at zero!
0 · Reply
NMax
NMax Mar. 17 at 3:21 PM
$OGEN The non-existant social media responses, and the negative market responses to Oragenics PRs show that this company is justifiably seen as a fraudulent shell company with fraudulent leadership that actively works to grift retail shareholders while waiting for an acquisition
0 · Reply
sincosine
sincosine Mar. 17 at 3:12 PM
$OGEN shit 💩 stock wow 🤩
0 · Reply
profitingstocks
profitingstocks Mar. 17 at 1:55 PM
$OGEN Janet received $609,000 total compensation in 2025 while the stock price tumbled 90%
1 · Reply
NMax
NMax Mar. 17 at 1:55 PM
$OGEN delighted to continue adding at this range despite Janet Huffmans ongoing BS to clear out retail 🤑🤑🤑
0 · Reply
Latest News on OGEN
ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION

Mar 12, 2026, 8:30 AM EDT - 5 days ago

ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION


Oragenics Q3 2025 Shareholder Update

Nov 12, 2025, 8:30 AM EST - 4 months ago

Oragenics Q3 2025 Shareholder Update


Oragenics Q2 2025 Shareholder Update

Aug 11, 2025, 8:45 AM EDT - 7 months ago

Oragenics Q2 2025 Shareholder Update


Oragenics Completes Approximately $16.5 Million Offering

Jul 2, 2025, 4:15 PM EDT - 9 months ago

Oragenics Completes Approximately $16.5 Million Offering


Oragenics, Inc. Announces Closing of Public Offering

Sep 5, 2024, 4:30 PM EDT - 1 year ago

Oragenics, Inc. Announces Closing of Public Offering


Oragenics, Inc. Announces Pricing of Public Offering

Sep 4, 2024, 8:36 AM EDT - 1 year ago

Oragenics, Inc. Announces Pricing of Public Offering


Oragenics, Inc. Announces Proposed Public Offering

Jun 24, 2024, 6:43 PM EDT - 1 year ago

Oragenics, Inc. Announces Proposed Public Offering


Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

May 17, 2024, 8:00 AM EDT - 1 year ago

Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine


Oragenics, Inc. Files 10K and Provides Company Update

Apr 1, 2024, 9:05 AM EDT - 2 years ago

Oragenics, Inc. Files 10K and Provides Company Update


Oragenics Announces Closing of Public Offering

Mar 1, 2024, 4:04 PM EST - 2 years ago

Oragenics Announces Closing of Public Offering


Oragenics Announces Pricing of Public Offering

Feb 27, 2024, 9:25 PM EST - 2 years ago

Oragenics Announces Pricing of Public Offering


Oragenics Announces Proposed Public Offering

Feb 27, 2024, 4:33 PM EST - 2 years ago

Oragenics Announces Proposed Public Offering


Oragenics, Inc. Announces Leadership Transition

Feb 12, 2024, 4:41 PM EST - 2 years ago

Oragenics, Inc. Announces Leadership Transition


Oragenics Issues Update to Shareholders

Nov 2, 2023, 7:00 AM EDT - 2 years ago

Oragenics Issues Update to Shareholders


TritiumH3
TritiumH3 Mar. 17 at 8:20 PM
0 · Reply
NMax
NMax Mar. 17 at 6:25 PM
$OGEN Janet Huffman and the Oragenics board have created a culture of distrust regarding their company and their NYSE listing, by seemingly repeatedly and intentionally defrauding their own investors while colluding with shorters such as Sabby
0 · Reply
RocketQueen
RocketQueen Mar. 17 at 5:25 PM
$OGEN what a garbage stock and company. Every time I learn something new about J. Vandlandingham it reminds of how much this is a scam and fraud. Take what's left of your investment here and put it in a market index ETF or a dividend stock like Coca Cola.
0 · Reply
profitingstocks
profitingstocks Mar. 17 at 4:13 PM
$OGEN $8M cash on their current burn rate will last them until October at the very latest, more likely to be much sooner than that. Meaning they’ll be issuing some of those 100,000,000 shares they have authorised for their ATM offering any day now, if they’re not already. Absolutely nothing to look forward to here - even if, by some miracle, they manage to create a product they can sell and make money from for the first time ever, they’ll have destroyed 99.9999% of the stock price by then through capital raises and toxic financing
0 · Reply
SXCross
SXCross Mar. 17 at 3:40 PM
$OGEN Short-Interesse 570.220 Aktien – Quelle: NYSE
0 · Reply
SXCross
SXCross Mar. 17 at 3:38 PM
$OGEN Something's not right here: Market capitalization 3.27 million. Cash 8 million. No debt! Product candidate is valued at zero!
0 · Reply
NMax
NMax Mar. 17 at 3:21 PM
$OGEN The non-existant social media responses, and the negative market responses to Oragenics PRs show that this company is justifiably seen as a fraudulent shell company with fraudulent leadership that actively works to grift retail shareholders while waiting for an acquisition
0 · Reply
sincosine
sincosine Mar. 17 at 3:12 PM
$OGEN shit 💩 stock wow 🤩
0 · Reply
profitingstocks
profitingstocks Mar. 17 at 1:55 PM
$OGEN Janet received $609,000 total compensation in 2025 while the stock price tumbled 90%
1 · Reply
NMax
NMax Mar. 17 at 1:55 PM
$OGEN delighted to continue adding at this range despite Janet Huffmans ongoing BS to clear out retail 🤑🤑🤑
0 · Reply
SXCross
SXCross Mar. 17 at 1:03 PM
$OGEN https://www.oragenics.com/news-media/press-releases/detail/230/oragenics-files-annual-report-on-form-10-k
0 · Reply
Roosterscanfly
Roosterscanfly Mar. 17 at 12:29 AM
$TOVX while $OGEN keeps bouncing around check this out too it's interesting $TSLA could be a monster on $ECOX from what I'm seeing $INUV has attention from Google, just waiting on a long term contract.
0 · Reply
NMax
NMax Mar. 16 at 7:13 PM
$OGEN Oragenics claimed it activated its first clinical trial site in Australia on March 12th, which would mean that are actively recruiting patients. According to the Australian clinical trial registry you can add that claim as another example (on a long list) of lieing/defrauding shareholders as they wait for their acquisition
0 · Reply
NMax
NMax Mar. 16 at 6:58 PM
$OGEN Janet Huffman and the oragenics board who appear to be colluding with shorters (sabby) against their own shareholders, while waiting for an acquisition.
0 · Reply
RocketQueen
RocketQueen Mar. 16 at 4:43 PM
$OGEN the plot thickens as I recently learned the inventor of this nasal snot (Jake V.) had previously sent money to the leader of an Africa based investment scam in Ghana. I can't make this stuff up. It just goes to show you how these scam artists at Orgenics do not care about shareholders and will sink your investment in projects doomed to failure.
1 · Reply
XAMN
XAMN Mar. 16 at 3:29 PM
$OGEN zero leadership as reflected by the price action Just a fraud named Janet Huffman apparently colluding with short sellers
0 · Reply
kenpr
kenpr Mar. 16 at 2:55 PM
$OGEN no surprise.. typical shit this company doing
0 · Reply
NMax
NMax Mar. 16 at 1:35 PM
$OGEN adding more this week! 🤑🤑🤑
1 · Reply
DARKP00L
DARKP00L Mar. 16 at 10:41 AM
0 · Reply
RocketQueen
RocketQueen Mar. 15 at 2:45 AM
$OGEN "For the majority of 2019, the federal welfare funds quietly flowed to a pharmaceutical startup with questionable financial prospects. The payments are one component of civil litigation the state is bringing against dozens of people or companies that misspent or improperly received welfare funds. A pleading filed Dec. 12 in the lawsuit alleges that the company’s founder, a defendant in the case, turned around and sent at least some of that money to an investment group in Ghana, Africa, for a venture that he thought would make him rich but turned out to be a scam".-Mississippi Today https://mississippitoday.org/2023/12/19/welfare-funds-ghana-scam-prevacus/
0 · Reply
RocketQueen
RocketQueen Mar. 14 at 6:42 PM
$OGEN not clear if Oragenics DD the nasal drug well enough: "I looked to see what the evidence was, that it really does what they say it does. And there is none," said Dr. Steven DeKosky, the deputy director of the McKnight Brain Institute at the University of Florida and a leading researcher in Alzheimer's disease and traumatic brain injury (TBI). And there's no proof that it would help ameliorate injury, much less prevent it." Said Dr. Daniel Weinberger, the director of the Lieber Institute for Brain Development and a professor of neuroscience at Johns Hopkins: "I don't believe there's any scientific evidence to support this claim for human use."-- https://www.espn.com/nfl/story/_/id/34971744/review-shows-favre-backed-drug-companies-overstated-benefits-connections
0 · Reply
RocketQueen
RocketQueen Mar. 13 at 11:40 PM
$OGEN there's no point in buying this trash above thirty cents as it will be out of compliance soon. No point in buying period.
0 · Reply